In an 80-year-old patient with acute lumbar discitis, which is more appropriate for pain management: methocarbamol or baclofen?

Neither Methocarbamol Nor Baclofen Should Be Used for Acute Lumbar Discitis Pain in an 80-Year-Old

In an 80-year-old patient with acute lumbar discitis, neither methocarbamol nor baclofen is appropriate for pain management, as both lack efficacy and carry significant risks in geriatric patients. If forced to choose between these two options, avoid both—but if absolutely necessary, methocarbamol has marginally less risk than baclofen in this age group, though it still provides no proven benefit.

Why These Agents Are Inappropriate

Methocarbamol: No Evidence of Efficacy

• Methocarbamol does not directly relax skeletal muscles and has no evidence of efficacy in chronic pain 1
• The FDA label explicitly states it "does not directly relax tense skeletal muscles in man" 2
• Recent high-quality evidence from 2022 showed that among ED patients with acute low back pain, methocarbamol provided no improvement over placebo (mean RMDQ improvement 8.1 vs 10.5 for placebo) 3
• A 2026 systematic review using the REB method found no efficacy for methocarbamol in acute low back pain 4
• Given the potential for adverse effects in older adults, these drugs are specifically not favored for pain management 1

Baclofen: Minimal Data and High Risk

• Baclofen is a GABA-B agonist used for spasticity, not for pain management
• Guidelines state there are "minimal data and risks of adverse effects" and these drugs are "only rarely considered for trials when neuropathic pain has been refractory to other therapies" 1
• The FDA label warns of sedation, CNS depression, and additive effects with other CNS depressants 5
• In geriatric patients, baclofen carries significant risks of confusion, falls, and respiratory depression 5
• While one 1985 study suggested benefit 6, a 2026 randomized trial found no additional benefit when baclofen was added to NSAIDs (p=0.21 for pain, p=0.18 for disability) 7

Critical Context: Discitis Is Not Simple Musculoskeletal Pain

Lumbar discitis is an infectious/inflammatory condition of the intervertebral disc space—this is fundamentally different from mechanical low back pain:

• The pain mechanism involves infection, inflammation, and potential spinal instability
• "Muscle relaxants" target muscle spasm in mechanical pain, which is not the primary pathology here
• The evidence cited for both drugs pertains to acute mechanical low back pain, not infectious discitis

What Should Be Used Instead

For an 80-year-old with acute lumbar discitis, appropriate pain management includes:

First-line options:

• Acetaminophen (with dose adjustment for age/hepatic function)
• NSAIDs (if no contraindications; adjust for GI and renal risk factors) 8
• Gabapentinoids (pregabalin 25-50 mg/day or gabapentin 100-200 mg/day starting dose) for neuropathic/radicular component 1

Second-line options:

• Duloxetine for neuropathic pain with favorable safety profile in elderly 8
• Tramadol (can be well-tolerated but monitor for cognitive effects) 8

Avoid:

• Traditional opioids unless severe refractory pain (high morbidity/mortality risk in elderly) 8
• Muscle relaxants including methocarbamol and baclofen (no proven benefit, significant adverse effects) 1, 3

Common Pitfalls to Avoid

1. Don't reflexively prescribe "muscle relaxants" for all back pain—discitis requires treatment of the underlying infection and inflammation, not muscle spasm
2. Don't assume older medications are safer—in geriatrics, newer agents like gabapentinoids or duloxetine often have better risk-benefit profiles than traditional muscle relaxants
3. Don't overlook polypharmacy risks—at age 80, CNS depressants like baclofen can cause falls, confusion, and respiratory depression 5
4. Don't ignore renal function—both pain medications and the patient's age require dose adjustments